Transdermal Prescription Gels

NEW YORK, Jan. 3, 2017 /PRNewswire/ -- Transdermal Prescription Gels - Products, Players, Markets and Forecasts

An Attractive Treatment Option
Transdermal gel systems for delivering systemic therapeutics are attractive to drug developers and formulators because they address some of the shortcomings associated with transdermal patch products. Advances in the areas of excipients, drug solubility and transdermal dosing are attracting new players and investors. We expect this market to experience healthy growth through 2009 as gel technology is applied to existing drugs and as gel formulations become a route of choice for the administration of new NCEs. Growth in this sector will also be driven by the pressure to extend market protection for numerous drugs with soon-to-expire patents, as well as Rx-to-OTC switching.


Market-driven Product Strategies
A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. To counteract the financial and medical infrastructure implications of this trend, pressure from the public sector and managed care organizations will place a premium on therapeutic self-administration, an expectation that is creating an increased interest in routes of administration that are patient-friendly and cost-effective. Pharma company decision makers have come to the realization that for many products, success no longer only depends on the medication itself but also on achieving a consumercompatible form of packaging and application.

'The formulation technologies covered in this report place increased emphasis on process development and process validation and their impact on manufacturing compliance. More than ever before process validation must begin in the laboratory at the earliest stages of process development, and be a continuous event that follows a process throughout its lifetime.'

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.


What You Will Learn
- What transdermal prescription gels are currently marketed or in development, who are the suppliers, and what are the product specifics?
- What are the therapeutic markets being targeted by transdermal gels?
- What are the essential formulation factors, technologies and market development issues facing transdermal prescription gel products?
- What are the major factors that will drive transdermal gel demand?
- What is the addressable market for transdermal prescription gels?
- What is the expected impact of transdermal gels on drug delivery markets?
- Who are the significant players in this segment? What are their strategies? Who are their alliance partners?


Report Value Chain – Who Should Read this Report

Development
- Drug Developers
- Device Suppliers
- CMOs
- Components/APIs
- Testing/Validation
- Clinical Trial Mgmt

ndustry
- Pharma Managers
- Biotech Managers
- Drug Marketers
- Industry Strategists
- Financial Analysts
- Management Consultants

Market
- Clinical Managers
- Drug Distributors
- Pharma Regulators
- FDA Consultants
- Managed Care Managers

Read the full report: http://www.reportlinker.com/p04487667-summary/view-report.html

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
 
http://www.reportlinker.com


__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/transdermal-prescription-gels-300385028.html

SOURCE Reportlinker